Side Effects of NAD+ Supplements for Older Adults

Weekly pill organizer with capsules and tablets on a kitchen counter beside glasses, water and fruit

Before you price a NAD+ product, ask what is known about how older adults tolerate it. The answer comes from a single trial.

What the one trial tested

The National Library of Medicine hosts a report of a 12‐week double‐blind, randomized, placebo‐controlled pilot study of the NAD+ precursor nicotinamide riboside (NR) in older adults with mild cognitive impairment. The study looked at safety, tolerability, and preliminary efficacy.

If you are weighing an infusion instead of a supplement, the science behind intravenous vitamin therapy covers a different route of delivery.

What it concluded

The National Library of Medicine paper concludes that NR is well tolerated in older adults with mild cognitive impairment. That is one compound studied in one group, so it does not speak for every NAD+ product on the market.

Healthline's guide to NAD+ infusion safety is the place to look if a clinic offers the infusion form.

What repeat use commits you to

A trial of that length says little about a year of repeat purchases. Ask any seller how long the product has been studied in people your age and who published the result.

WebMD's page on NAD therapy for addiction covers a different use, so keep it apart from claims about supplements for older adults.

Which reader each choice fits

An older reader who is considering NAD+ should bring the paper to their own clinician before buying a multi-month supply. A reader who wants a firm answer on long-term side effects will not get one from a single pilot.